221 related articles for article (PubMed ID: 19346495)
1. The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development.
Wilson NK; Miranda-Saavedra D; Kinston S; Bonadies N; Foster SD; Calero-Nieto F; Dawson MA; Donaldson IJ; Dumon S; Frampton J; Janky R; Sun XH; Teichmann SA; Bannister AJ; Göttgens B
Blood; 2009 May; 113(22):5456-65. PubMed ID: 19346495
[TBL] [Abstract][Full Text] [Related]
2. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.
Chan WY; Follows GA; Lacaud G; Pimanda JE; Landry JR; Kinston S; Knezevic K; Piltz S; Donaldson IJ; Gambardella L; Sablitzky F; Green AR; Kouskoff V; Göttgens B
Blood; 2007 Mar; 109(5):1908-16. PubMed ID: 17053063
[TBL] [Abstract][Full Text] [Related]
3. Gfi1 expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/Tal1, Gata2, PU.1, Erg, Meis1, and Runx1 acting as upstream regulators in early hematopoietic cells.
Wilson NK; Timms RT; Kinston SJ; Cheng YH; Oram SH; Landry JR; Mullender J; Ottersbach K; Gottgens B
Mol Cell Biol; 2010 Aug; 30(15):3853-63. PubMed ID: 20516218
[TBL] [Abstract][Full Text] [Related]
4. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
5. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.
Landry JR; Kinston S; Knezevic K; de Bruijn MF; Wilson N; Nottingham WT; Peitz M; Edenhofer F; Pimanda JE; Ottersbach K; Göttgens B
Blood; 2008 Mar; 111(6):3005-14. PubMed ID: 18184866
[TBL] [Abstract][Full Text] [Related]
6. Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis.
Kassouf MT; Chagraoui H; Vyas P; Porcher C
Blood; 2008 Aug; 112(4):1056-67. PubMed ID: 18550854
[TBL] [Abstract][Full Text] [Related]
7. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer.
Nottingham WT; Jarratt A; Burgess M; Speck CL; Cheng JF; Prabhakar S; Rubin EM; Li PS; Sloane-Stanley J; Kong-A-San J; de Bruijn MF
Blood; 2007 Dec; 110(13):4188-97. PubMed ID: 17823307
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.
Zhou RQ; Wu JH; Gong YP; Guo Y; Xing HY
Blood Cells Mol Dis; 2014; 53(1-2):39-46. PubMed ID: 24405580
[TBL] [Abstract][Full Text] [Related]
9. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development.
Pimanda JE; Ottersbach K; Knezevic K; Kinston S; Chan WY; Wilson NK; Landry JR; Wood AD; Kolb-Kokocinski A; Green AR; Tannahill D; Lacaud G; Kouskoff V; Göttgens B
Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17692-7. PubMed ID: 17962413
[TBL] [Abstract][Full Text] [Related]
10. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.
Gekas C; Rhodes KE; Gereige LM; Helgadottir H; Ferrari R; Kurdistani SK; Montecino-Rodriguez E; Bassel-Duby R; Olson E; Krivtsov AV; Armstrong S; Orkin SH; Pellegrini M; Mikkola HK
Blood; 2009 Apr; 113(15):3461-71. PubMed ID: 19211936
[TBL] [Abstract][Full Text] [Related]
11. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
Landry JR; Bonadies N; Kinston S; Knezevic K; Wilson NK; Oram SH; Janes M; Piltz S; Hammett M; Carter J; Hamilton T; Donaldson IJ; Lacaud G; Frampton J; Follows G; Kouskoff V; Göttgens B
Blood; 2009 Jun; 113(23):5783-92. PubMed ID: 19171877
[TBL] [Abstract][Full Text] [Related]
12. SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells.
Real PJ; Ligero G; Ayllon V; Ramos-Mejia V; Bueno C; Gutierrez-Aranda I; Navarro-Montero O; Lako M; Menendez P
Mol Ther; 2012 Jul; 20(7):1443-53. PubMed ID: 22491213
[TBL] [Abstract][Full Text] [Related]
13. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the Scl +19 enhancer increases the blood stem cell compartment without affecting the formation of mature blood lineages.
Spensberger D; Kotsopoulou E; Ferreira R; Broccardo C; Scott LM; Fourouclas N; Ottersbach K; Green AR; Göttgens B
Exp Hematol; 2012 Jul; 40(7):588-598.e1. PubMed ID: 22401818
[TBL] [Abstract][Full Text] [Related]
15. Tal1/SCL binding to pericentromeric DNA represses transcription.
Wen J; Huang S; Pack SD; Yu X; Brandt SJ; Noguchi CT
J Biol Chem; 2005 Apr; 280(13):12956-66. PubMed ID: 15677454
[TBL] [Abstract][Full Text] [Related]
16. Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)-dependent window during hematopoietic stem-cell development.
Schlaeger TM; Mikkola HK; Gekas C; Helgadottir HB; Orkin SH
Blood; 2005 May; 105(10):3871-4. PubMed ID: 15677556
[TBL] [Abstract][Full Text] [Related]
17. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
Göttgens B; Broccardo C; Sanchez MJ; Deveaux S; Murphy G; Göthert JR; Kotsopoulou E; Kinston S; Delaney L; Piltz S; Barton LM; Knezevic K; Erber WN; Begley CG; Frampton J; Green AR
Mol Cell Biol; 2004 Mar; 24(5):1870-83. PubMed ID: 14966269
[TBL] [Abstract][Full Text] [Related]
18. Dynamic shifts in occupancy by TAL1 are guided by GATA factors and drive large-scale reprogramming of gene expression during hematopoiesis.
Wu W; Morrissey CS; Keller CA; Mishra T; Pimkin M; Blobel GA; Weiss MJ; Hardison RC
Genome Res; 2014 Dec; 24(12):1945-62. PubMed ID: 25319994
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators.
Tijssen MR; Cvejic A; Joshi A; Hannah RL; Ferreira R; Forrai A; Bellissimo DC; Oram SH; Smethurst PA; Wilson NK; Wang X; Ottersbach K; Stemple DL; Green AR; Ouwehand WH; Göttgens B
Dev Cell; 2011 May; 20(5):597-609. PubMed ID: 21571218
[TBL] [Abstract][Full Text] [Related]
20. The SCL 3' enhancer responds to Hedgehog signaling during hemangioblast specification.
Hochman E; Kinston S; Harmelin A; Göttgens B; Izraeli S
Exp Hematol; 2006 Dec; 34(12):1643-50. PubMed ID: 17157160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
